Matinas BioPharma gets NYSE American non-compliance notice
Matinas BioPharma Holdings said it received a notice on Aug. 31, 2026 from NYSE American LLC stating it is not in compliance with continued listing standards.
BEDMINSTER, N.J., Sept.
04, 2026 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (the “Company”) (NYSE American: MTNB) announced today that on August 31, 2026, it received a notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) stating that the Company is not in compliance wit…